HomeMy WebLinkAboutMerck PedvaxHIBProduct and Company Identification
SAFETY DATA SHEET
Liquid PedvaxHIB™
1.
Page: 1/6
Revision 8-Oct-2007
PRODUCT NAME:
Liquid PedvaxHIB™Label Name
Chemical Name Haemophilus b Conjugate Vaccine (Meningococcal Protein
Conjugate)
Not availableSynonyms
MERCK & CO., INC.
One Merck Drive
Whitehouse Station, NJ 08889-0100
(908) 423-1000
Emergency Telephone Number: 1-732-594-5555
Manufactured/Supplied by
Intended Use Vaccine indicated for routine vaccination against invasive disease
caused by Haemophilus influenzae type b in infants and children 2
to 71 months of age.
Material Product Number No. 4897 — A box of 10 single-dose vials of liquid vaccine
NDC 0006-4897-00
Composition/Information on Ingredients2.
Component CAS Number Percent (%)
Haemophilus b Conjugate
Vaccine (Meningococcal
Protein Conjugate)
Not available Not available Not available <0.1
Aluminum
hydroxyphosphate sulfate
Not available Not available 20257-20-9 <0.1
Inactive Ingredients - - - Not available - - - >99.9
Molecular weight
EC Label
Molecular Formula
Not classified.
Hazards Identification3.
Appearance
Label Text
Avoid direct contact with skin and eyes. Wash thoroughly after
handling. No immediate hazard from intact vials.
Slightly opaque white liquid
CAUTION!
VACCINE
Potential Health Effects See Section 11 for detailed information.
Emergency Overview
*** Continued on next page ***
Liquid PedvaxHIB™Product name Page: 2/6
Revision 8-Oct-2007
Do NOT induce vomiting unless directed to do so by medical
personnel. Get medical attention if symptoms appear.
Skin Contact
In case of contact, flush eyes with plenty of water. Get medical
attention if symptoms occur.
Wash with soap and water.Get medical attention if irritation
develops.
4.
If inhaled, remove to fresh air. Get medical attention if symptoms
appear.
Notes to physician Treat supportively and symptomatically.
For additional guidance refer to the current prescribing information
or the local poison control center.
Ingestion
Inhalation
Eye Contact
First Aid Measures
Fire Fighting Measures5.
Hazardous Decomposition Products None known.
In case of fire, use water spray (fog), foam, dry chemical, or CO2.Extinguishing Media
Not applicableFlammable Limits (% in air)
Autoignition Temperature Not available
No special procedures.
Fire/Explosion Hazards None known.
Combustibility Information
Dust Explosivity Information
Shock Sensitivity
Not available
Not applicable
Not applicable
Not availableOxidizing Properties
Special Fire Procedures
Flash Point Not applicable
Personal Precautions
6. Accidental Release Measures
See Section 8 for Personal Protective Equipment. Contact
emergency personnel. Keep unnecessary personnel away.
Follow all fire fighting procedures (Section 5).
Methods for cleaning up Contain spilled material. For small spills add absorbent (soil may
be used in the absence of other suitable materials) scoop up
material and place in a sealed, liquid-proof container for disposal.
For large spills dike spilled material or otherwise contain material
to ensure runoff does not reach a waterway. Place spilled material
in an appropriate container for disposal. Minimize contact of
spilled material with soils to prevent runoff to surface waterways.
See Section 13 for Waste Disposal Information.
For additional assistance in the U.S., CHEMTREC provides a toll-free Hotline for chemical emergencies
regarding spills, leaks, exposure or accidents: 1-800-424-9300.
For emergency calls from outside the U.S.: 1-703-527-3887
*** Continued on next page ***
Liquid PedvaxHIB™Product name Page: 3/6
Revision 8-Oct-2007
Handling
Handling and Storage
Storage
7.
Avoid direct contact with skin and eyes. Wash thoroughly after
handling.
In the absence of specific storage recommendations, keep
container in a cool, well-ventilated area. Keep container tightly
closed.
8. Exposure Controls/Personal Protection
Personal Protective Equipment
Adequate ventilation should be provided if there is risk of aerosol formation. None required when handling
sealed vials.
Exposure Guidelines
Haemophilus b Conjugate
Vaccine (Meningococcal
Protein Conjugate)
Not established Not established PB-ECL 3*
Aluminum hydroxyphosphate
sulfate
Not available Not available Not available
Inactive Ingredients Not available Not available Not available
Eye/Face Protection Safety glasses with side shields should be worn when handling
bulk liquid formulation or filling vials. None required when handling
sealed vials.
Additional body garments should be used based upon the task
being performed (e.g., sleevelets, apron, gauntlets, disposable
suits) to avoid exposed skin surfaces. None required when
handling sealed vials.
Skin Protection
Respiratory Protection No respiratory protection required when handling bulk liquid
formulation or sealed vials. As an adjunct to engineering controls,
use an approved, properly fitted, powered air purifying respirator,
or respirator of equivalent or greater protection if the potential
exists for exposure to airborne aerosols.
Work uniform or laboratory coat.Additional Protective Equipment
Engineering Controls
Component OSHA Permissible
Exposure Limit
(PEL)
ACGIH Threshold Limit
Value
(TLV)
Merck Exposure Control
Limit (ECL)
or PB-ECL Category
*Corresponds to 10-100 ug/m3 as an 8-hr TWA.
PB-ECL category is an internal Merck control band.
Not available
Physical and Chemical Properties
Melting Point
Boiling Point
Not available
pH
Flash point Not applicable
9.
Not available
Not availableOdor/Threshold Limit
Appearance Slightly opaque white liquid
*** Continued on next page ***
Liquid PedvaxHIB™Product name Page: 4/6
Revision 8-Oct-2007
Vapor Pressure
Vapor Density
Solubility
Not available
Not available
Not available
Not available
Not applicableFlammable Limits (% in air)
Not availablePartition Coefficient
Autoignition Temperature
Specific Gravity Not available
Volatility Component Not available
Hazardous Decomposition Products
Conditions to Avoid Not available
Stability and Reactivity
None known.
Not availableStability
10.
Not available
Hazardous Polymerization Not available
Incompatibility
Toxicological Information11.
Effects of Acute Exposure
Inhalation Not available
Not availableIngestion
Skin contact Not available
Not availableEye contact
Toxicity Data
Component Test Species Route Result
Haemophilus b Conjugate
Vaccine (Meningococcal
Protein Conjugate)
Not available Not available Not available Not available
Aluminum hydroxyphosphate
sulfate
Not available Not available Not available Not available
This compound is a vaccine indicated for routine vaccination
against invasive disease caused by Haemophilus influenzae type b
in infants and children 2 to 71 months of age. PedvaxHIB showed
no adverse effects in general safety testing conducted in guinea
pigs and mice. Because the lipopolysaccharide (LPS) contained
by OMPC has the capacity to elicit a pryogenic response when the
LPS is biologically accessible, pyrogenicity tests through
intramuscular and intravenous routes were developed and are
conducted in rabbits. Release criteria require that no significant
temperature rise is observed in these tests. PedvaxHIB has not
been evaluated for its carcinogenic, mutagenic potential, or the
potential to impair fertility.
The most frequently reported (>1%) adverse reactions, without
regard to causality, were fever (>101°F), irritability, sleepiness,
Effects of Chronic Exposure
Routes of Entry Ingestion:
Inhalation:
Skin Contact:
No.
Yes
No.
*** Continued on next page ***
Liquid PedvaxHIB™Product name Page: 5/6
Revision 8-Oct-2007
Medical Conditions Aggravated by
Overexposure:
Not available
injection-site pain/soreness, injection-site erythema (<2.5 cm
diameter), injection-site swelling/induration (<2.5 cm diameter),
unusual high-pitched crying, prolonged crying (>4 hours), diarrhea,
vomiting, crying, pain, otitis media, rash, and upper respiratory
infection.
Not listed as a carcinogen by OSHA, NTP or IARC.Carcinogen Designation
Ecological Information12.
Ecotoxicity Data
Component Species Period Result
Haemophilus b Conjugate
Vaccine (Meningococcal
Protein Conjugate)
Not available Not available Not available
Aluminum hydroxyphosphate
sulfate
Not available Not available Not available
Inactive Ingredients Not available Not available Not available
Environmental Fate Not available
Environmental Effects Not available
Disposal Considerations13.
Avoid contact of spilled material and runoff with soil and surface
waterways. Dispose of or treat all spill residues including
contaminated soils following all applicable regulations.
Waste Disposal Information
14. Transport Information
Not regulated.U.S. DOT
IATA/ICAO Not regulated.
IMO Not regulated.
ADR/RID Not regulated.
Shipping Description
Regulatory Information15.
U.S. Federal Regulations
International Regulations Not classified as Dangerous according to the Dangerous
Substances Directive (DSD).
Not hazardous per OSHA Hazard Communication Standard
criteria (29 CFR 1910.1200)
State Regulations Not available
*** Continued on next page ***
Liquid PedvaxHIB™Product name Page: 6/6
Revision 8-Oct-2007
Other Information16.
Revision:10/8/2007.
Disclaimer:
While this information and recommendations set forth are believed to be accurate as of the date hereof,
MERCK & CO, INC. makes no warranty with respect hereto and disclaims all liability from reliance thereon.
MSDS Coordinator:1-908-423-7903
Merck & Co., Inc.
Two Merck Drive
P.O. Box 200, WS2W-13
Whitehouse Station, NJ 08889-0200
U.S.A.